LINC01119
gene geneOn this page
Summary
LINC01119 (long intergenic non-protein coding RNA 1119, HGNC:49262) is a long non-coding RNA gene on chromosome 2p21.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49262 |
| Approved symbol | LINC01119 |
| Name | long intergenic non-protein coding RNA 1119 |
| Location | 2p21 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000239332 |
| Entrez | 100134259 |
| RNAcentral | URS000075CEA4 — lncRNA, 1210 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 84.01.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9749 / max 48.6229, expressed in 230 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20113 | 0.5174 | 158 |
| 20114 | 0.1808 | 82 |
| 20115 | 0.1271 | 65 |
| 20118 | 0.0679 | 38 |
| 202183 | 0.0655 | 30 |
| 20112 | 0.0163 | 3 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 84.01 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.84 | gold quality |
| placenta | UBERON:0001987 | 74.91 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.76 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 73.58 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 72.42 | gold quality |
| mucosa of stomach | UBERON:0001199 | 72.10 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 69.12 | gold quality |
| pancreatic ductal cell | CL:0002079 | 69.04 | silver quality |
| ileal mucosa | UBERON:0000331 | 67.74 | silver quality |
| deltoid | UBERON:0001476 | 67.59 | silver quality |
| muscle of leg | UBERON:0001383 | 67.08 | gold quality |
| gastrocnemius | UBERON:0001388 | 66.59 | gold quality |
| left adrenal gland | UBERON:0001234 | 66.58 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 66.37 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 66.31 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.18 | gold quality |
| right adrenal gland | UBERON:0001233 | 66.05 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 65.82 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 65.46 | gold quality |
| upper arm skin | UBERON:0004263 | 65.44 | gold quality |
| lower esophagus | UBERON:0013473 | 65.42 | gold quality |
| putamen | UBERON:0001874 | 65.10 | gold quality |
| adrenal cortex | UBERON:0001235 | 64.54 | gold quality |
| adrenal gland | UBERON:0002369 | 64.52 | gold quality |
| ventricular zone | UBERON:0003053 | 64.40 | gold quality |
| nucleus accumbens | UBERON:0001882 | 64.00 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 63.44 | gold quality |
| caudate nucleus | UBERON:0001873 | 63.33 | gold quality |
| right coronary artery | UBERON:0001625 | 62.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.58 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000005361 (2:46849647 C>G,T), RS1000099227 (2:46839392 C>A,G,T), RS1000101751 (2:46833802 G>A), RS1000129360 (2:46852409 C>G), RS1000334503 (2:46857569 G>A), RS1000544786 (2:46848561 G>A,T), RS1000555584 (2:46853311 A>G), RS1000614844 (2:46847435 G>T), RS1000682644 (2:46826012 G>T), RS1000694802 (2:46853097 G>C,T), RS1000699976 (2:46827063 T>A), RS1000854933 (2:46829688 T>C), RS1000962932 (2:46853289 C>T), RS1001057115 (2:46843857 C>A,T), RS1001071675 (2:46858510 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, affects methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| boron nitride | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Tungsten Compounds | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.